Leptin and Beyond: An Odyssey to the Central Control of Body Weight by Li, Min-Dian
1
YALE JOURNAL OF BiOLOGY AND MEDiCiNE 84 (2011), pp.1-7.
Copyright ﾩ 2011.
REViEw
Leptin and Beyond: An odyssey to the central
control of Body Weight
Min-Dian Li
Department of Cellular and Molecular Physiology, Combined Programs in Biological and
Biomedical Sciences, Section of Comparative Medicine, Integrative Cell Signaling, and
Neurobiology of Metabolism (ICSNM), Yale University School of Medicine, New Haven,
Connecticut
The 2010 Lasker Award for basic medical research was shared by Douglas Coleman and Jef-
fery Friedman for their discovery of leptin, a breakthrough that revealed insight into the genetic
basis of obesity. This mini-review aims to review landmark studies on the physiologic system
of body weight control. The basic research on the leptin system has broad implications for the
genetic control of body weight, thus contributing to solve the global obesity crisis.
“The elation of peering into the depths of
nature and being the first to see something
new is impossible to describe.”
— Jeffery M. Friedman
introduction
Douglas Coleman and Jeffery Fried-
man shared the 2010 Albert Lasker Basic
Medical Research Award for their discov-
ery of a fat cell-produced hormone, leptin
(Greek leptos means thin). The discovery
was a landmark event in modern physiol-
ogy [1]. Friedman is widely recognized for
cloning the leptin gene ob that reverses
obesity and metabolic abnormalities in a
severely obese mutant mouse strain ob/ob
[1,2]. Leptin is an adipocyte hormone that
informs the brain of the status of energy
stores in peripheral tissues [1-3]. The dis-
covery of leptin not only closed the long
hypothesized physiologic feedback loop
that controls energy homeostasis around a
set point, but also markedly accelerated our
knowledge of the roles that genetics and
neuroendocrinology play in obesity, a se-
vere, costly public-health problem [1-8].
Here I briefly review the seminal work
done by Friedman and his precursors and
summarize the history and current research
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the PAth to discovery
Since Hippocrates’ influential observa-
tion that weight can be controlled by “de-
ciding” to eat less and exercise more, the
view that body weight is under the tight con-
trol of an endocrine system was not quite
widely shared [2,3]. The old dogma was
challenged when Gordon Kennedy proposed
the lipostat theory in 1953 [2,9,10]. It was
stated that fat mass serves as the set point of
energy balance, in which fat depots feed-
back onto the hypothalamus (the brain re-
gion responsible for feeding behavior) and
signal the energy requirement [9]. Kennedy
proposed that the feedback factors could be
circulating metabolites. However, as would
be illuminated decades later, they can also
be hormones.
Experimental support for this regula-
tory system emerged slowly. In 1959, based
on the Hetherington and Ranson study in
1942 showing lesions in hypothalamus can
cause  obesity  in  rats,  G.R.  Hervey  pre-
sciently proposed the existence of a signal
that suppresses food intake and weight in
rats via the parabiotic experiments [11,12].
He surgically connected the circulatory sys-
tem via subcutaneous tissues between nor-
mal rats and those with lesions in the ventral
medial hypothalamus (VMH†), which were
known to cause obesity [10,12]. The VMH-
lesioned rats were obese as expected. Sur-
prisingly,  the  normal  rats  that  were
connected to the obese decreased their food
intake  and  lost  substantial  weight  [12].
Without a functional VMH, the rats could
not respond to the satiety signal, thus they
became obese and overproduced the signal
as Hervey postulated. Through circulation
exchange, the excess of the satiety signal
suppressed the food intake and weight in
normal mice. This hypothesis is remarkably
prescient  considering  the  complexity  of
parabiotic models [1]. The task of identify-
ing the circulating satiety signal was daunt-
ing, and thus left the results attractive but
inconclusive.
Prior to the era of genetic models of en-
ergy balance, the lesions study was proba-
bly the primary approach to analyze and
locate regulatory sites, yet it was imprecise.
In 1949, a colony of mice showing severe
obesity was identified at The Jackson Labo-
ratory, which brought the genetic approach
into  the  field  [13].  The  mutation  was
mapped to chromosome 6 and designated
obese (ob). A second mouse strain with obe-
sity syndrome was identified by Doug Cole-
man and his associates in 1966 [14]. Mice
homozygous for the mutation that was des-
ignated diabetes (db) showed dramatic early
onset obesity, insulin resistance, hyperpha-
gia (over-eating), and physical inactivity.
The  important  findings  came  out  when
Coleman et al. conducted a series of parabi-
otic  experiments  with  ob/ob,  db/db,  and
wild-type mice. When ob/ob mice were con-
nected to either wild-type or db/db ones,
they decreased feeding and lost weight, and
this effect was reversed after disconnection.
The counterpart animals were unaffected by
connection with ob/ob animals [15]. In sharp
contrast, wild-type mice stopped eating and
lost weight substantially when connected to
db/db mice. Yet db/db animals were not af-
fected. Coleman proposed that ob/ob mice
lacked a circulating satiety factor that regu-
lates  feeding  and  weight.  Furthermore,
db/db mice  overproduced  the  circulating
factor but could not respond to it. Based on
Hervey’s observation, Coleman surmised
that the hypothalamus probably contains the
center that responds to the circulating sati-
ety factor [15]. In summary, observations
from multiple laboratories came to the hy-
pothesis that body weight is under the con-
trol of an endocrine system in which fat
depots gauge the energy balance and proba-
bly release a circulating hormone, encoded
by the ob gene, to inform the hypothalamus
via its receptor, the DB protein, of the sati-
ety/hunger status.
The essential endeavor after Coleman’s
seminal parabiotic studies was to identify
the nature of the ob gene. There were two al-
ternative approaches. One was the tradi-
tional  biochemical  approach,  which
attempted to purify the hormone; the other
2 Li: Leptin and central regulation of body weightwas the novel genetic approach taken by Jef-
fery  Friedman:  positional  cloning  [2].
Through a heroic eight-year odyssey, Fried-
man and his colleagues finally cloned the
gene in 1994. They demonstrated that the ob
gene as a 4.5 kb transcript expressed exclu-
sively in adipose tissue [2,16]. Soon after
this classic report, the Friedman laboratory
and two other groups demonstrated that ad-
ministration of the recombinant OB peptide
ameliorated the ob phenotype, thus substan-
tiating the role of OB as a hormone regulat-
ing body weight [17-19]. Moreover, brain
administration  of  OB  peptide  influenced
feeding behavior, suggesting OB can act di-
rectly on the neural circuits that regulate
feeding and energy balance [19]. It was con-
sistent with Coleman’s prediction that the
circulating factor, OB, acts on the hypothal-
amic satiety center. Based on these findings,
Friedman named the peptide “leptin” from
the Greek root leptos for “thin” [1]. 
An avalanche of discoveries followed.
Lee et al. from the Friedman laboratory and
Chen et al. identified the db locus as a gene
encoding a family of leptin receptors that are
alternatively spliced, with the spliced form
OB-Receptor b (OB-Rb) having a long in-
tracellular domain functional in the hypo-
thalamus [20,21]. Among the six alternative
spliced  forms,  only  OB-Rb  is  expressed
strongly in the hypothalamus and was pre-
dicted to mediate signaling via the Janus Ki-
nase (JAK)/Signal Transducer and Activator
of Transcription (STAT) pathway. Naturally,
Vaisse et al. from the Friedman laboratory
demonstrated that systemic administration
of leptin activates STAT3 specifically and
exclusively in the hypothalamus of wild-
type and ob/ob mice but not db/db mice,
which lack leptin receptor [22], suggesting
that leptin receptor mediates the leptin’s ef-
fect onto STAT3.
These  findings,  together  with  other
studies, elucidated the endocrine system that
regulates body weight via metabolism and
feeding behavior (Figure 1). The status of fat
stores in the adipose tissues dictates the syn-
thesis and release of the hormone leptin.
Weight loss causes a decrease in serum lep-
tin levels, while feeding cues, such as insulin
and glucose, increase serum leptin levels
[3,23,24]. Leptin feeds back on the regula-
tory centers in the brain, thus controlling
metabolism and feeding. Absence of either
the hormone or the receptor predisposes ro-
dents to obesity. Thus the network of the lep-
tin system has a profound implication on
obesity and human metabolic diseases. 
Considering both leptin deficiency and
unresponsiveness  account  for  obesity  in
mouse models, it was expected that leptin
deficiency would be a major factor in obese
humans.  Indeed,  low  leptin  levels  were
found in a small but significant fraction of
obese humans (5 percent to 10 percent) [3].
However, leptin treatment of obese humans
had variable effects [25]. Surprisingly, high
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Figure 1. Leptin and regulation of Body
Weight. Leptin is synthesized and released
by fat adipose tissue, which constitutes a
negative feedback loop that regulates body
weight. it circulates in the blood and acts
on the hypothalamus via binding to leptin
receptors. The plasma leptin level is pro-
portional to the fat mass. when fat mass
decreases, plasma leptin level falls, initiat-
ing the activation of orecxigenic responses
and the repression of anorexigenic re-
sponses. Thus food intake is enhanced and
energy expenditure is inhibited until fat
mass is restored. when fat mass in-
creases, plasma leptin level increases, thus
inhibiting food intake and increasing energy
expenditure via concerted actions of hypo-
thalamic neural circuits. Overall, the body
weight is maintained in an intricate balance
by the leptin signaling system. serum  leptin  is  associated  with  obesity
(known as leptin resistance), indicating ei-
ther the adaptation of the leptin system to a
new set point or the dysfunction of leptin
signaling [3,26]. Therefore, leptin is not the
whole story for central regulation of body
weight but rather a landmark for a new ini-
tiative exploring the mechanisms.
LePtin And interPLAys oF 
centrAL neurAL circuits in
the hyPothALAmus
In the energy balance equation, energy
store is determined by energy intake and en-
ergy expenditure, both of which are regu-
lated by the hypothalamus [27]. Leptin acts
primarily on the hypothalamus, influencing
behavior and metabolism [16-19]. The dis-
covery of leptin prompted researchers to ex-
plore the central neural circuits and their
interactions with the leptin signaling.
Since leptin actions on the hypothalamus
depend on the presence of leptin receptor,
studies on the localization of leptin receptors
ushered in soon. Fei et al. from the Friedman
lab found OB-Rb, the one responsible for the
db phenotype, is expressed in the arcuate nu-
cleus (ARC), ventromedial (VMH), dorso-
medial  (DMH),  and  lateral  (LH)
hypothalamic nuclei, but is not detectable in
other brain regions via polymerase chain re-
action (PCR) [28]. These regions are known
to regulate food intake and energy expendi-
ture. Lesion studies in rodents (in some cases,
humans) demonstrated that disruption of the
ARC, VMH, and DMH resulted in hyper-
phagia and obesity [27,29-34], whereas le-
sions in the LH caused hypophagia [35]. The
dual-center model identifies the VMH as the
“satiety center” and the LH as the “hunger
center” [36]. Thus the studies by Fei et al. and
others highlight the dominant role of leptin
signaling in the central regulation of energy
balance [28,37-39].
Another  equally  important  direction
was the hypothalamic target molecules of
leptin. Right after the discovery of the ob
gene, Stephens et al. proposed leptin regu-
lates food intake and metabolism in part via
inhibition of the synthesis and release of
neuropeptide Y (NPY), which stimulates
food intake and decreases thermogenesis
[40]. However, even before the discovery of
leptin,  arcuate  nucleus  NPY  neurons  via
their connection to pro-opiomelanocortin
(POMC) cells were proposed to regulate
feeding [41]. Indeed, later studies showed
that  leptin  inhibits  neural  pathways  that
stimulate food intake (orexigenic) and de-
crease energy expenditure, as well as acti-
vates neural pathways that inhibit feeding
(anorexigenic) [3,10,42]. Orexigenic neu-
ropeptides include NPY and Agouti-related
peptide (AgRP), whereas anorexigenic sig-
nals  contain  ʱ-melanocortin-stimulating
hormone  (ʱ-MSH,  a  cleaved  product  of
POMC). 
The neurons that are marked by AgRP
or  POMC  and  the  neurons  expressing
melanocortin receptors (MCR) comprise the
melanocortin system, which regulates long-
term energy balance [10,42]. ARC nucleus
is composed of two specific neurons, POMC
and NPY/AgRP [42]. An exceptionally at-
tractive and simple model depicting the in-
terplays between leptin signaling and the
central regulation of feeding is described
thusly: Leptin activates POMC neurons via
firing rates and gene expression; activated
POMC  neurons  release  ʱ-MSH  into  the
synapses, which activates the projected neu-
rons  via  binding  to  MCRs  and  leads  to
anorexigenic responses and increased en-
ergy expenditure. Simultaneously, leptin in-
hibits NPY/AgRP neurons, offsetting the
antagonistic  effect  of  AgRP  on  MCRs
[43,44]. NPY/AgRP neurons stimulate orex-
igenic responses and inhibit POMC neurons
via direct synaptic connection [41,45]. No-
tably, there is no feedback from POMC neu-
rons to NPY/AgRP neurons, indicating the
default function of the neural circuit is to
promote food intake [10,42]. The impor-
tance of the melanocortin system is exem-
plified not only by these findings that leptin
directly acts on this circuit in the hypothal-
amus but also by the fact that loss of func-
tion of the MC-4R, the major MCR, is the
most common genetic cause of human obe-
sity, accounting for 3 precent to 5 percent of
severe obesity in humans [46,47].
4 Li: Leptin and central regulation of body weightIn short, leptin regulates energy balance
by modulating the activity and gene expres-
sion of NPY/AgRP neurons and POMC neu-
rons in the ARC. To add a new layer of
regulation, Pinto et al. from the Horvath
group identified rapid rewiring of the ARC
neural circuit by leptin [48]. The synapses
projected to NPY/AgRP neurons and POMC
neurons were different between ob/ob mice
and wild type mice. Leptin treatment nor-
malized the synaptic density on these neu-
rons within six hours, several hours before
leptin’s effects on food intake. These find-
ings suggest leptin also acts on the hypo-
thalamus via neural plasticity.
concLusions And outLook
The identification of ob/ob mice was
the first evidence from animal studies to il-
luminate the genetic basis of obesity. Fried-
man’s discovery of leptin has provided the
conclusive evidence for an endocrine system
that regulates feeding and metabolism via
communication from fat tissues to brain,
which is the primary statement of the lipo-
stat theory. From the perspective of physiol-
ogy,  fat  mass  gauges  the  energy  stores;
leptin  signaling  communicates  from
adipocytes to hypothalamus, the center that
regulates numerous physiologic and behav-
ioral processes, including metabolism and
feeding; leptin influences feeding via the
ARC melanocortin system, modulating neu-
ral activity, gene transcription, and circuit
plasticity; and the ARC integrates informa-
tion from the VMH (the satiety center) [49]
and  other  brain  regions  and  instructs  its
downstream neural circuit to affect feeding
and metabolism through hormonal and neu-
ral pathways, thus bringing the energy sta-
tus to normal (Figure 1).
Over the last 16 years, researchers have
learned much more about the biology and
physiology of leptin. Yet much remains un-
known. Whether leptin is the only signal for
energy balance is an open question. The
brain is in a constant demand for fuel mole-
cules. For example, 70 percent of glucose is
utilized by the brain, which represents only
2 percent of body weight. Fuel molecules
and their downstream products have been
hypothesized to sense the energy status in
situ. In other words, neurons in the ARC and
VMH can modulate their activity in direct
response to fluctuations in glucose, free fatty
acids, and amino acids [10]. Thus it is at-
tempting to study the nutrient-sensing mech-
anisms  within  the  brain,  especially  the
POMC  neurons,  namely  adenosine
monophosphate activated kinase (AMPK)
pathways, reactive oxygen species (ROS)
pathways, mammalian target of rapamycin
(mTOR) pathways [10].
How the ARC neurons integrate signal-
ing  and  control  feeding  behavior  is  also
under avid investigation. In 2005, Sternson
et al. from the Friedman laboratory reported
direct projections from the satiety center,
VMH, to the ARC neurons. Of interest, in a
population level, medial VMH neurons proj-
ect excitatory synapses onto POMC neu-
rons,  but  not  NPY  neurons  [49].  NPY
neurons only receive weak inhibitory synap-
tic projections within the ARC [49]. These
findings support the idea that food intake
(orexigenic) is the default function of mam-
malian, including human, neural circuits.
Besides the crosstalk between different brain
regions, there are also neural pathways con-
necting the hypothalamus and peripheral tis-
sues.  Using  virus  to  trace  neuronal
projections, Stanley et al. from the Friedman
laboratory identified subpopulations of neu-
rons from the hypothalamus projecting to
two metabolic active tissues, liver and white
adipose [50]. The delineations of these neu-
ral pathways will facilitate functional analy-
sis  of  how  the  hypothalamus  regulates
feeding behavior and metabolism.
How cellular leptin resistance is linked
to obesity is a debated topic [26]. Analogous
to  insulin  resistance  in  metabolic  syn-
dromes, leptin resistance coexists with obe-
sity  in  most  cases.  Whether  the  blunted
response to elevated leptin levels predates or
adapts to obesity is not known [26]. More-
over, induction of cellular attenuation of lep-
tin  signaling  complicates  the  causal
relationship between leptin resistance and
obesity. Of note, Knight et al. recently found
diet-induced obese mice whose leptin levels
5 Li: Leptin and central regulation of body weightwere clamped to lean levels remained sensi-
tive to exogenous leptin, suggesting hyper-
lepinemia contributes to leptin resistance
[51]. However, additional research is re-
quired to verify this issue.
Central regulation of body weight is
closely relevant to human health. The dys-
function of leptin and its downstream com-
ponents contributes to monogenic obesity.
The United States is in a severe obesity epi-
demic. Over the past decade, obesity has be-
come recognized as a national health threat
and  a  major  public  health  challenge.  In
2009, only Colorado and the District of Co-
lumbia had a prevalence of obesity less than
20 percent. Thus the elucidation of leptin
and its actions in the central neural circuit
will help solve the national crisis. More than
50 years of research has established the li-
postat model of body weight control. Yet re-
searchers are still in the odyssey to a full
understanding of molecular mechanisms.
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